1169
CLINICAL UTILITY OF NEXT-GENERATION SEQUENCING FOR DIFFERENTIATING MAIN-DUCT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM AND CHRONIC PANCREATITIS AS ETIOLOGY OF PANCREATIC DUCT DILATION
Date
May 21, 2024
Tracks
Related Products
THE CLINICAL IMPACT AND COST-EFFECTIVENESS OF DIAGNOSTIC MODALITIES FOR INDETERMINATE BILIARY STRICTURES, INCLUDING NEXT-GENERATION SEQUENCING AND ARTIFICIAL INTELLIGENCE: A MICROSIMULATION ANALYSIS
Indeterminate biliary strictures persist as a diagnostic challenge, particularly due to the concern of delayed diagnosis of malignancy…
INCORPORATING NEXT-GENERATION SEQUENCING IN THE MANAGEMENT ALGORITHM OF PANCREATIC CYSTS
BACKGROUND: Pancreatic cancer (PC) features highly proliferative cancer cells and a dense stroma modulating tumor growth. Due to the invasive behavior of PC and the lack of effective treatments, there is a pressing need to develop therapies targeted at tumorigenic events to slow down PC progression…
A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…
Advances in Barrett's Esophagus
SOCIETY: AGA